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ABSTRACT 
 
Objective: This review provides a brief account of the clinically relevant functional 
neuroanatomy of the thalamus, before considering the utility of various modalities utilised to 
image the thalamus and technical challenges therein, and going on to provide an overview of 
studies utilising structural imaging techniques to map thalamic morphology in the spectrum 
of neurodegenerative disorders. 
 
Methods: A systematic search was conducted for peer-reviewed studies involving structural 
neuroimaging modalities investigating the morphology (shape and/ or size) of the thalamus 
in the spectrum of neurodegenerative disorders. 
 
Results: Whilst the precise role of the thalamus in the healthy brain remains unclear, there is 
a large body of knowledge accumulating which defines more precisely its functional 
connectivity within the connectome, and a burgeoning literature implicating its involvement 
in neurodegenerative disorders. It is proposed that correlation of clinical features with 
thalamic morphology (as a component of a quantifiable subcortical connectome) will provide 
a better understanding of neuropsychiatric dysfunction in various neurodegenerative 
disorders, potentially yielding clinically useful endophenotypes and disease biomarkers. 
 
Conclusions: Thalamic biomarkers in the neurodegenerative disorders have great potential 
to provide clinically meaningful knowledge regarding not only disease onset and progression, 
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but may yield targets of and perhaps a way of gauging response to future disease-modifying 
modalities. 
 
Key words 
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“Essentially, the cortex must view the world through the thalamus: that is the only view the 
cortex has.” Sherman and Guillery, 2006. 
 
INTRODUCTION 
 
Framing the thalamus in the context of endophenotypes. 
There has been a marked shift in the approach to characterizing and understanding 
neuropsychiatric disease with a focus upon endophenotypes that has driven change in 
research paradigms (Gottesman and Gould, 2003). The concept of intermediate phenotypes 
(or endophenotypes) has been described as, “measurable components unseen by the 
unaided eye along the pathway between disease and distal phenotype” (Gottesman and 
Gould, 2003). Accordingly, correlation between genetic factors and measurements of the 
neural circuit substrates of cognition, emotion, motor function and behavior may constitute 
steps towards establishing a genotype to morphotype relationship. The morphotype thus 
derived may then determine the phenotype (see Looi and Walterfang, 2012).  
 
In this paper, we apply the framework of the endophenotypes and its antecedents in the 
endomorphotypes (morphology) and ultimately (though not currently) the endogenotype to 
understand the involvement of a crucial network hub in the human brain, the thalamus, in 
neurodegenerative disease. We argue that: the thalamus serves as a crucial hub in the 
extensive topographically distinct neuronal networks relevant to human brain disease and its 
manifestations; the morphology (shape and volume) of the thalamus can be quantified in 
vivo; quantified morphology (morphometry) may be correlated to endophenotypic features 
of the disease such as impairments in cognition, emotion, motor function and behavior; and 
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therefore, morphometry of the thalamus may be used to measure disease progression as a 
potential biomarker.  
 
BASIC AND CLINICAL NEUROANATOMY OF THE THALAMUS 
 
Historical aspects 
The term thalamus is from the Greek word thalamos (θάλαμος), referring to an inner-most 
room but also used to describe storeroom and a sleeping or bridal chamber; the word was 
used commonly in ancient Greek texts, such Homer’s Odyssey. The first documented 
neuroanatomical usage of the word was by Galen in the second century AD when using as an 
analogy the floor plan of a Greek house, but it is quite likely he was referring to a part of the 
ventricular system (possibly as a ‘storeroom’ of pneuma), rather than what is referred to as 
the thalamus today; Thomas Willis, in the mid to late 1600s, was the first to refer to the large 
mass of grey matter in the dorsal part of the diencephalon as the thalamus (see Jones, 2007).  
 
Embryology and gross anatomy of the thalamus 
During development the primitive forebrain gives rise to the telencephalon (or end-brain), 
which has as its derivatives the cerebral cortex, striatum, amygdala, and associated 
structures, and the diencephalon (or between-brain), which gives rise primarily to the 
thalamus and hypothalamus. It is likely that connections between the thalamus and cortex 
occur after subcortical afferents have innervated the thalamus, with corticothalamic 
connections preceding thalamocortical connections. Hence, maturation of the thalamus and 
cortex are related intimately, such that an abnormality in the early neurodevelopmental 
period of thalamic organization could impair normal cortical development, and vice versa; 
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consistent with a neurodevelopmental model, it has been proposed that pathology of the 
thalamus may play an important role in the neurobiology of schizophrenia (see Byne et al., 
2009). 
 
Whilst the diencephalon can be generally divided into the thalamus and hypothalamus, it 
includes a number of other structures (such as the habenular nuclei of the epithalamus). The 
thalamus itself can be divided into the dorsal and ventral divisions, based on their relative 
position in the lateral diencephalic wall during development, and also on the basis of their 
connectivity (Jones, 2007). The dorsal thalamus is composed of nuclei having reciprocal 
connections with the cerebral cortex and striatum, whilst the ventral thalamus (despite 
having direct input from the cortex and, in part from the basal ganglia) does not project to 
the cortex. The ventral thalamic nuclei include the reticular thalamic nucleus (RTN), zona 
incerta (ZI) and ventral lateral geniculate nucleus, and a shared feature of these nuclei 
appears to be projections to and a close anatomical and functional relationship with the 
dorsal thalamus (Mitrofanis and Guillery, 1993; Power et al., 1999; Kolmac et al., 2000; 
Mitrofanis, 2005). From a neuroanatomical and neuroimaging perspective, the RTN and ZI 
assist with the lateral and inferior boundary definition, respectively, throughout much of the 
rostral-caudal extent of the dorsal thalamus (Power et al., 2015). This review will focus 
primarily on the dorsal thalamus unless otherwise stated.  
 
Occupying approximately the volume of a Brazil nut (Bertholletia excelsa) in the human, the 
two dorsal thalami are located strategically at the very ‘inner-most’ region of the brain, 
between other subcortical structures and cortex (see Figure 1). Gross anatomical landmarks 
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defining the boundaries of the thalamus are as follows: the third ventricle serves as the medial 
boundary, and the internal capsule separates the thalamus from the basal ganglia laterally; 
superiorly the thalamus is bound by the lateral ventricle, and inferiorly a number of distinctive 
structures abut the thalamus (including the ZI, substantia nigra, subthalamic nucleus, red 
nucleus). The dorsal thalamus has anterior, medial and lateral subdivisions, defined by a 
curved sheet of myelinated fibres called the internal medullary lamina (Figure 2). These 
subdivisions are composed of distinct thalamic nuclei, defined on the basis of their 
cytoarchitecture, patterns of connectivity and functionality (see Table 1, Figures 1, 2), 
however these nuclei share many features in common as outlined below. The anterior 
subdivision is defined by the anterior nucleus (AN) and the medial subdivision by mediodorsal 
nucleus (MD). The lateral subdivision has a dorsal and ventral tier of nuclei: the dorsal tier 
contains the lateral dorsal nucleus (LD) and the pulvinar; the ventral tier contains the ventral 
anterior (VA), ventral lateral (VL) and ventral posterior (VP) nuclei. Sometimes considered as 
a caudal extension of the ventral tier are the lateral geniculate (LGN) and medial geniculate 
(MGN) nuclei (which are found inferior to the pulvinar). The internal medullary lamina itself 
also encloses the intralaminar nuclei (IL); the midline nuclei (ML) cover portions of the medial 
surface of the dorsal thalamus.  
 
Genetic factors involved in neurodevelopment 
The neurodevelopment of the thalamus has been summarized extensively (see Jones, 2007; 
and Blackshaw et al., 2010), and the following is a brief synopsis to establish that there are 
significant genetic factors involved in development. A relatively small number of gene sets 
are thought to be expressed in the developing diencephalon, with 3 major compartments 
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identified (p1, p2, and p3) (Puelles and Rubenstein, 2003), and a mid-diencephalic organiser 
(Scholpp et al., 2009) releasing several signalling factors crucial to thalamic organisation, 
including Sonic hedgehog (SHH) and fibroblast growth factor (FGF) (Bulfone et al., 1993).  
 
A recent study reported that genetic variation within the Human Leukocyte Antigen locus 
(previously associated with schizophrenia) influences the volume of the left thalamus 
(Brucato et al., 2015). Further studies will need to ascertain the genetic factors associated 
with thalamic volume. A correlation between genetic factors and thalamic volume may 
constitute a step towards establishing a genotype to morphotype relationship. The 
morphotype thus derived may then determine the phenotype (see Looi and Walterfang, 
2012).  
 
Physiology 
There are two types of neurons in dorsal thalamic nuclei which can be distinguished by their 
unique morphology and chemoarchitecture: locally acting interneurons immunoreactive for 
γ-aminobutyric acid (GABA), and glutamatergic relay cells projecting outside of the thalamus 
(which have a variety of voltage dependent membrane properties). The physiological 
properties of thalamic relay cells suggests that they have two main types of response modes 
- either tonic or burst - which will determine the nature of the message relayed to the cortex, 
and these response modes are thought to underpin changes in behavioral states. A burst 
response mode is utilized for signal detection, or salience (for instance, in response to novel 
stimuli or sudden changes in the environment), whereas a tonic response mode is believed to 
be utilized by the thalamic relay cells for more accurate signal analysis (Crick, 1984; Sherman 
and Guillery, 2006). The response mode of thalamic relay cells (i.e., shifting from signal 
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analysis to signal detection, and vice versa) is thought to be modulated by brainstem and 
cortical inputs to the thalamus; it has been suggested that disturbance of this process may 
underpin the aberrant salience seen in neuropsychiatric disease (for instance see Byne et al., 
2009). 
 
Drivers and modulators  
The nuclei of the dorsal thalamus are innervated by two types of afferent fibres, classified as 
either drivers or modulators; this classification is regardless of whether the fibres originate 
from cortical or subcortical structures (see Figure 3). Afferent fibres can be defined on the 
basis of their synaptic morphology (e.g., drivers have large terminals on proximal dendrites 
forming multiple contacts, whereas modulators have small terminals on distal dendrites 
forming single contact) and post synaptic actions (e.g., drivers activate ionotropic receptors 
and cause large excitatory postsynaptic potentials (EPSP), whereas modulators also activate 
metabotropic receptors, and cause small EPSP). The key feature of the modulator axon is that 
its terminals are less well-grouped than those of the driving axon terminals; further, 
modulator afferents send a branch to innervate the RTN, whereas driver afferents do not 
(Bourassa et al., 1995; Darien-Smith et al., 1999). A key feature of driver afferents is that they 
determine the thalamic relay cell receptive field, whereas modulators do not. Drivers can 
therefore be conceptualized as those afferents to the thalamus that carry the message to be 
passed on by the thalamic relay cell, whilst the modulators can be conceptualized as those 
afferents to the thalamus that influence how this message is passed on by the thalamic relay 
cell. In other words, the drivers may ‘make’ the message, whilst the modulators ‘adjust’ the 
message. 
 
9 
 
First order and higher order nuclei 
The nuclei of the dorsal thalamus can be categorized according to the afferent fibres they 
receive (i.e., driver or modulator fibres) (see Figure 3). The cells of first order nuclei (or 
‘primary’ nuclei; e.g., LGN, MGN, VP) are innervated by drivers originating from a peripheral 
or subcortical structure, and receive feedback inputs (modulator afferents) from pyramidal 
cells in layer VI of the ipsilateral cortex (these cortical afferents also send branches to the RTN 
and this circuitry appears to have a modulatory function). In the configuration of this 
connectivity, visual, auditory and somatosensory afferent fibres bring peripheral information 
pertaining to their respective sensory modality to the first order nuclei of the thalamus (Figure 
3).  
 
In contrast to first order nuclei, higher order nuclei (or association nuclei; e.g., pulvinar, MD) 
receive their primary excitatory inputs (or drivers) from pyramidal cells in layer V of the 
ipsilateral cortex. These particular inputs to the higher order nuclei resemble the main 
peripheral or subcortical inputs to the first order nuclei, not only in the nature of their 
structure and synapses they make, but also in that they lack a branch to the RTN (Guillery, 
1995). In the configuration of this connectivity, cells of higher order nuclei are involved in the 
passage of information (for instance with regard to the current output of the driving cortical 
area) from one cortical area to another via a transthalamic pathway (Figure 3); at least half of 
the thalamus is thought to be involved with this kind of signaling. Whilst this challenges the 
traditional understanding of cortico-cortical communication, it is suggested that direct 
cortico-cortical pathways may be providing some other function (e.g., modulatory; Sherman 
and Guillery, 2006). Hence it has been proposed that the higher order nuclei, which are well 
developed in humans, have a significant role in higher cortical functions, with the implication 
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that impairments of such signaling could lead to dysfunctional cortical processing (see 
Guillery, 1995; see Sherman and Guillery, 2006).  
 
Maps in the thalamus 
Some of the early studies of visual pathways reported rapid retrograde cell degeneration in a 
restricted column of visual thalamus (LGN) following localized lesions in the visual cortex, 
together with localized visual field losses (Kaas et al., 1972); subsequent trans-neuronal 
retrograde degeneration in the corresponding retinae were noted. These findings suggested 
there was a map of the visual field not only in the visual cortex, but also in the visual thalamus. 
It is now well established that many of the afferent and efferent connections of the thalamus 
are mapped (see example of sensorimotor mapping in Figure 4). This not only includes driver 
afferents to first order nuclei (such as visual afferents to LGN, auditory afferents to MGN, and 
somatosensory afferents to VP) but also conservation of these maps in thalamic circuitry, with 
topographically organized first and higher order thalamocortical and corticothalamic 
pathways.  
 
One suggested mechanism in neurodegenerative disease is trans-synaptic 
neurodegeneration: it is proposed that deafferentation from damaged cortical neurons 
causes synaptic dysfunction and this process leads to a neuronal propagation of disease along 
the related and therefore susceptible neural circuits (Palop and Mucke, 2009; Jidahra et al., 
2012; Looi and Walterfang, 2012). Trans-synaptic degeneration could be one of a number of 
processes that leads to subcortical pathologies seen in the striatum in Huntington’s disease 
(HD), frontotemporal dementia (FTD) and Alzheimer’s disease (AD) for instance, where there 
is subcortical neuronal loss (Looi and Walterfang, 2012; Looi et al., 2012). A parallel 
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explanation may also exist in the form of the putative propagation of proteopathies (protein 
misfolding or prions) along the same neural circuits, also resulting in topographically distinct 
patterns of neural loss in most age-related neurodegenerative disease (Warren et al., 2013). 
Indeed it is also possible that proteopathies may also contribute to trans-synaptic 
neurodegeneration, though of course this does not exclude deafferentation phenomena. 
Similar mechanisms are likely to be at play in the other circuit structures, or hubs (such as the 
thalamus) in neurodeenerative disorders (Looi et al., 2014). Given the topographical 
relationship that the thalamus has with the cortex, one would envisage that investigating 
thalamic morphology may provide disease-specific maps of structural change in the cortical 
afferent pathways in various neurodegenerative conditions (Power and Looi, 2014; Power et 
al., 2015). Not surprisingly, the effect of cortical lesions in animal studies has been shown to 
have different effects on the receptive field properties of cells in the first order versus higher 
order thalamic nuclei: receptive fields of cells in first order nuclei (which receive 
corticothalamic modulator afferents) survive, whereas those of the relay cells of the higher 
order nuclei (which receive corticothalamic driver afferents) are lost (see Sherman and 
Guillery, 2006).  
 
A critical hub in the subcortical connectome 
There are numerous well-defined neural circuits involving the thalamus in addition to those 
already described, such as the fronto-subcortical circuits which are proposed to underpin 
motor activity and behaviour in humans (see Figure 5); further, fronto-subcortical circuit 
dysfunction may also explain the likeness of behavioral changes seen in a plethora of frontal 
cortical and subcortical disorders (Cummings, 1993; Tekin and Cummings, 2002; Haber and 
Calzavara, 2009; Looi et al., 2012). 
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 Fronto-subcortical circuits are named according to their function or site of origin in the cortex 
(e.g., ‘motor’ circuits: motor, oculomotor; and ‘cognitive’ circuits: dorsolateral prefrontal, 
orbitofrontal, and anterior cingulate) (see Figure 5); importantly, the functional topography 
of cortex is maintained throughout these circuits. The circuits share a similar organization, 
originating in the prefrontal cortex, then projecting to the striatum (caudate, putamen, 
ventral striatum), having connections with the globus pallidus and substantia nigra, and 
thence to the thalamus, which ‘closes’ the loop by projecting back to the prefrontal cortex 
(Figure 5). There are also ‘open’ connections of each of these circuits, which are thought to 
integrate information from functionally related sites. Within each of these circuits there are 
both direct and indirect pathways, which can modulate input to the thalamus, the function of 
which is thought modulate overall circuit activities in response to different inputs (Tekin and 
Cummings, 2002). There is also emerging evidence that fronto-subcortical circuits can 
influence each other (see Haber and Calzavara, 2009), suggestive of integrative processing. 
This schema has provided a useful approach to neurodegenerative conditions on a neural 
circuit basis, on the rationale that delimited subsets of neuropsychiatric dysfunction may 
share a common neural circuit basis (Cummings, 1993; Looi et al., 2012). In 
neurodegenerative disease it is proposed that cortical or subcortical lesions may disconnect 
fronto-subcortical circuits, and it is the circuit dysfunction that underpins the neuropsychiatric 
presentation for that disease. Such fronto-subcortical circuit dysfunction is thought to 
mediate the cognitive and behavioral disturbances manifest in FTD, for instance (Hodges and 
Patterson, 2007; Looi et al., 2012; Looi and Walterfang, 2012).  
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In a similar framework, a large body of structural and functional imaging studies have defined 
the cerebellothalamocortical circuits, linking functional areas of cerebellar cortex through the 
thalamus with both motor and non motor cerebral cortex, as indicated in Figure 6 (see 
Middleton and Strick, 1994). Functional imaging during cognitive tasks, together with 
tractography demonstrates cerebellar projections through motor and intralaminar thalamus 
to prefrontal cortex, supporting the role of these circuits not only in motor but also cognitive 
processing (Prevosto and Summer, 2013). It has been proposed that dysfunction of 
cerebellothalamocortical circuits may underpin the manifest emotional and cognitive 
dysfunction in a range of neuropsychiatric conditions (Schmahmann, 2004; Konarski et al., 
2005; Andreasen and Pearson, 2008).  
 
As such, the thalamus may be considered a crucial hub in the network of subcortical 
structures that underpins significant intra- and inter-hemispheric circuit connectivity, known 
collectively as the subcortical connectome (see Looi et al., 2014). Therefore, further 
investigating the thalamus and its topographically distinct morphology is likely to yield 
important information across the broad spectrum of neuropsychiatric conditions.  
 
Thalamic function and dysfunction 
Classically the thalamus has been referred to as ‘the gateway’ to the cortex as it was thought 
that the dorsal thalamus was limited to functioning as a relay of information; in this respect 
it has been regarded as a group of cells that are concerned with passing information on to the 
cerebral cortex about the activity of either the periphery or other parts of the central nervous 
system. The thalamus has also been linked to many more functions, for example in 
transferring information between different cortical areas (Guillery, 1995), influencing states 
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of arousal through its connections with the brainstem and basal forebrain (Steriade and 
Deschenes, 1984), sharpening or synchronization of input from the cortex (Sillito et al., 1994) 
and generating salience (Crick, 1984). 
 
The current conceptualization of thalamic function is as a modulatory gate, with thalamic 
relay cells conveying the message from their driving afferent fibre (either cortical or 
subcortical) to the cortex. Transmission of the message occurs with the thalamic relay cell 
either in burst or tonic modes, without a significant change in the message from the driving 
afferent. The relay of information is influenced by a range of modulatory inputs, adjusting the 
way in which the information is relayed rather than altering the nature of the relayed 
information. One of the many but key challenges facing neuroscientists investigating the 
thalamus is to clarify precisely what benefit is obtained by sending information through the 
thalamus before it reaches the cortex. As postulated by Sherman and Guillery (2006), an 
advantage of higher order nuclei and transthalamic corticortical communication could be 
that, “the thalamus could serve as the organ of reflection of cortical activity back upon itself”; 
they argue that the role of the thalamus in perceptual processing is likely to be significant and 
speculate that a function of thalamocortical inputs to cortex (either from relay cells of first 
order or higher order thalamic nuclei) could be to keep the cortex updated on the most recent 
motor commands (Sherman and Guillery, 2006).  
 
Taken together, when considering the role of the thalamus in neurological and psychiatric 
disorders one could therefore consider dysfunction of the neural circuits involving the 
thalamus and a failure of modulatory gating, rather than neuropsychiatric symptoms 
somehow arising directly from the thalamus itself. 
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 NEUROIMAGING THE THALAMUS  
 
Neuroimaging has been used as a means to visualize and measure the thalamus in vivo and 
we propose that this can lead towards a quantitative morphology, otherwise known as 
morphometry.  
 
Modalities utilized for imaging the thalamus 
Whilst a range of functional imaging modalities can be utilized to estimate thalamic function, 
structural imaging techniques have a higher spatial resolution than functional imaging 
methods, ideal for investigating diminutive subcortical structures. With the evolution of 
structural MRI modalities and advanced image analytic methods, more precise quantification 
of changes in the size and shape in subcortical structures such as the thalamus can be 
achieved. In terms of structural MRI, meta-analyses have reported thalamic atrophy in 
schizophrenia (Adriano et al., 2010) and major depressive disorder (Du et al., 2012), but not 
in bipolar disorder (Hallahan et al., 2011). Thalamic atrophy has been reported in in both 
sporadic AD (de Jong et al., 2008) and in the pre-symptomatic stage of familial AD (Lee et al., 
2013; Ryan et al., 2013), as well as in progressive supranuclear palsy (PSP) (Whitwell et al., 
2011), FTD (Cardenas et al., 2007; Chow et al., 2008) and HD (Kassubek et al., 2005). 
 
Analytical methods [(e.g., spherical harmonic point distribution method (SPHARM-PDM) 
(Styner et al., 2006); radial distance mapping (Madsen et al., 2010)] measure the surfaces of 
neural structures using 3 dimensional models (or mathematical ‘meshes’) allowing 
comparison of surface regions of a structure between diagnostic groups. These methods can 
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expose statistically significant regional volume differences in the thalamus, which can provide 
important information regarding which underlying subdivisions or nuclei of the thalamus 
could be affected in the disease state being investigated (see McKeown et al., 2008).   
 
Thalamic nuclei can also be defined by their patterns of thalamocortical connectivity (see 
Table 1), hence diffusion tensor imaging (DTI) and tractography is a useful modality that 
enables one to visualize discrete white matter neural tracts, allowing the subdivisions and 
nuclei of thalamus to be imaged according to preselected cortical areas. DTI has been utilized 
to divide the thalamus into thalamocortical domains (Jakab et al., 2012), and this modality 
has the potential to yield specific localization of functional activations or lesions to putative 
thalamic nuclei. Given that most of the afferent and efferent fibres of the thalamus are 
mapped, DTI will be pivotal in further exploring the role of the thalamus in neurodegenerative 
disorders. Mapping of the thalamus within widespread networks will also be greatly 
facilitated by advances in resting state fMRI, and better understand the distinct spatio-
temporal courses of various neurodegenerative disorders (Zhou et al., 2012).  
 
Furthermore, merging these newer techniques (e.g., generated statistical shape models and 
connectivity maps) and advanced modalities (e.g., either DTI or PET and matching 
sophisticated MRI scanning and advanced analytical techniques) has the potential when 
correlated with clinical features to further enhance our understanding of various 
neuropsychiatric disorders (see McKeown et al., 2008; and Whitwell et al., 2011). Hence, 
advances in neuroimaging modalities will increasingly enable researchers to more precisely 
quantify the disease effect on thalamic morphology.  
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Technical challenges 
There are a number of challenges faced when attempting morphological analysis of the 
thalamus, namely associated with thalamic boundary definition within the constraints of the 
resolution afforded by current imaging technologies. Defining the inferior boundary is 
particularly problematic along the intercommissural distance, and utilizing distinctive nuclei 
(such as the red nucleus and subthalamic nucleus) and white matter tracts as landmarks is 
imperative (Figure 1); the nuclei of the ventral thalamus (in particular the RTN and ZI) that 
partly encapsulate the dorsal thalamus throughout its rostral-caudal extent can also enhance 
inferior and lateral boundary definition (rather than being included in morphological analysis 
with the dorsal thalamus) (see Power et al., 2015) (Figure 1). The rostral pole of the dorsal 
thalamus is particularly challenging, and in order to exclude it from the adjacent 
hypothalamus and capture the full extent of this boundary, it has been suggested thalamic 
tracing should ideally occur with brain slices no greater than 1mm thickness and proceed in a 
caudal to rostral direction (the caudal pole being readily identifiable as the pulvinar) (see 
Power et al., 2015). A number of automated approaches to mapping thalamic morphology, 
whilst having research utility as they can deal efficiently with a large numbers of brain scans, 
have thus been limited in their ability to precisely define thalamic boundaries (see Andreasen 
et al., 1994); studies utilizing automatic segmentation protocols often report larger mean 
thalamic volumes (Zarei et al., 2010; Ryan et al., 2013). Manual segmentation of the thalamus 
has therefore been utilized as the preferred approach, particularly in the setting of significant 
inter-individual variability of the thalamus and its component nuclei (see Spinks et al., 2002; 
Uylings et al., 2008).  
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A number of groups have published validated protocols for manual segmentation of the 
thalamus using structural MRI, however the majority lack detailed information regarding 
precise boundary definition (see Power et al., 2015 for review). Many studies employ the 
approach published by Portas and colleagues (1998) who detailed an approach manual 
segmentation in 20-21 consecutive coronal 1.5mm slices in a rostral-caudal direction; whilst 
providing a comprehensive description of adjacent land marks, there is little information to 
guide manual tracing of the challenging inferior boundary and rostral pole, for instance. There 
are similar limitations in the protocol published by Spinks and colleagues (2002), involving 12 
coronal 1.5mm slices, however an advancement of their technique was the utilization of three 
imaging modalities (T1, T2 and PD weighted images) and functions within the software 
package (BRAINS2) to assist with boundary definition. Our own group has recently published 
a protocol of manual segmentation using 28-30 consecutive 1mm coronal slices using 
ANALYZE 11.0 software addressing many of the limitations and building on some of the 
advances of previous works (Power et al., 2015).  
 
It is anticipated that advanced neuroimaging protocols for manual segmentation of the 
thalamus using structural MRI will drive the emergence of technologies towards more precise 
automated segmentation techniques of the human thalamus, which would improve efficiency 
both in the clinical and research setting. For the time being, further research is required in 
order to investigate the correlation of newer protocols with existing automated techniques. 
Whatever strategies emerge, they will need to be widely accessible, inexpensive (e.g., using 
software freely available on the web) and generalizable (i.e., use techniques that can be 
incorporated across a variety of software packages) in order for them to be relevant. 
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THALAMIC MORPHOLOGY IN NEURODEGENERATIVE DISORDERS 
 
Conceptualization of neurodegenerative disorders on a neural circuit basis.  
Two key features characterize most age-related neurodegenerative disorders, the first being 
abnormal folding and accumulation of disease-specific proteins (sometimes termed 
‘proteopathic’ agents) such as tau, beta amyloid or synuclein, and the second being 
progressive pathological change across the neuraxis (Braak and Braak, 1991; Braak et al., 
2003; Deng et al., 2004; Kril and Halliday, 2011) (see Figure 7). The mechanism of disease 
‘spread’, particularly by extant neuronal networks, has become an important research focus, 
on the rationale that by better understanding such mechanisms one could potentially develop 
treatment modalities to halt the spread of disease throughout the brain. 
 
Stemming from advances in the understanding the mechanism by which abnormal prion 
proteins lead to neurodegenerative processes (Prusiner, 1982; Aguzzi and Polymenidou, 
2004), similar frameworks have been applied to investigating neurodegeneration in a range 
of disorders. Researchers have attempted to ‘seed’ proteopathic agents such as beta amyloid 
and tau in animal models, and various lines of evidence have suggested that spread of seeded 
protein aggregates occurs in distinct spatial (i.e., anatomical) and temporal patterns (for 
review see Walker and LeVine, 2012). Researchers subsequently proposed that different 
neurodegenerative disorders have patterns of disease spread that is characteristic, with the 
clinical correlate being a distinctive clinical syndrome for that disorder (i.e., a characteristic 
temporal constellation of cognitive, emotional, behavioral and motor features) (see Brundin 
et al., 2010; and Polymenidou and Cleveland, 2012). Following advances in methods such as 
graph theory to better understand neural circuitry (Bullmore and Sporns, 2009), and 
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combined with structural and functional neuroimaging, a more recent conceptualization of 
neurodegenerative disorders on a neural circuit basis has emerged (Brundin et al., 2010) (see 
Figure 7). Researchers propose that proteopathic agents take seed in a specific part of the 
neuraxis and then spread throughout the brain’s intrinsic pathways over time, causing neural 
damage and/ or dysfunction through a range of mechanisms in both cortical and subcortical 
structures (Seeley et al., 2009; Zhou et al., 2012; Raj et al., 2012; Warren et al., 2013). 
 
Neuroimaging studies in the common neurodegenerative disorders have tended to focus on 
dysfunctional neocortical rather than subcortical circuits, the most parsimonious explanation 
being that neocortex dysfunction was thought to underpin the cognitive dysfunction that 
often presents early in disease. There is a burgeoning body of literature identifying the 
important role of subcortical structures in these circuits and contributing to cognitive 
disturbance in neurodegenerative disorders, such as the striatum in AD, behavioral variant 
FTD, progressive nonfluent aphasia (PNFA) and stroke (de Jong et al., 2008; Seeley et al., 2009; 
Looi et al., 2009; Zhou et al., 2012; Looi et al., 2012). To date, relatively few studies have 
investigated thalamic morphology in the neurodegenerative disorders; as a pivotal structure 
in the subcortical connectome such investigations are likely to be fruitful (see Looi et al., 2014; 
Power and Looi, 2014; Power et al., 2014). 
 
Thalamic morphology in healthy aging 
In a study of 57 healthy subjects ranging in age from 21-82 years of age who underwent 
neurocognitive testing (Stroop test and Pencil Memory Scanning Test) and structural MRI, a 
decrease in thalamic volume was reported across the lifespan (van der Werf et al., 2001); this 
decrease in thalamic volume was reported to be independent of the decrease in total brain 
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volume, and found to occur prior to it. Thalamic atrophy was found to start early in the 
lifespan and have a linear association with advancing age; the same study reported that 
thalamic atrophy correlated with diminished performance on tests of processing speed (van 
der Werf et al., 2001). More normative data is needed regarding thalamic morphology across 
the lifespan.  
 
Thalamic morphology in Alzheimer’s dementia 
Thalamic atrophy on MRI has been reported in sporadic AD relative to controls (Callen et al., 
2001; de Jong et al., 2008; Zarei et al., 2010). Further, thalamic atrophy in AD is associated 
independently with cognitive deterioration using the CAMCOG-R and MMSE in a cohort of 
memory clinic patients diagnosed with probable AD (n=69) relative to those without objective 
memory deficits (“memory complainers”, n=70) when controlled for age, gender, educational 
level, intra cranial volume and neocortical grey matter volume (de Jong et al., 2008). 
Combining shape and connectivity analysis in 16 patients with AD compared with 22 healthy 
controls, Zarei and colleagues (2010) reported bilateral atrophy in the regions of the MD 
nuclei of the thalamus (in regions connected with prefrontal and temporal cortex, and 
hippocampus), as well as bilateral atrophy in anterodorsal regions of the thalamus (which 
they attributed to possible internal medullary lamina atrophy). Their findings are, in part, 
consistent with reports of amyloid deposits and neurofibrillary tangles in the limbic nuclei of 
the thalamus, especially the MD and sub regions of the AN, and involving the IL nuclei (Braak 
and Braak, 1991; Xuereb et al., 1991). 
 
In familial AD, thalamic atrophy (Lee et al., 2013; Ryan et al., 2013) and increased fractional 
anisotropy of the thalamus bilaterally (Ryan et al., 2013) has been reported in the pre-
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symptomatic stage of disease, consistent with amyloid imaging studies demonstrating that 
amyloid deposition first occurs in the striatum and thalamus in pre-symptomatic cohorts (see 
Knight et al., 2011). Longitudinal studies of thalamic morphology in both sporadic and familial 
AD are warranted.  
 
Thalamic morphology in parkinsonian disorders 
In the early stages of PSP and PD, these disorders can be difficult to distinguish, and definitive 
diagnosis is established by postmortem observation of characteristic histological 
abnormalities and regional pathology. Whilst neuronal loss is seen post mortem in the 
intralaminar thalamic nuclei in both PSP and PD, degeneration in motor thalamus is reported 
in PSP, but not PD (Henderson et al., 2000; Halliday et al., 2005); the authors speculate that 
dysfunction of cerebellothalamic pathways in PSP may be an important distinguishing feature. 
Hence, the identification of distinguishing features on MRI between PSP and PD (and other 
parkinsonian disorders, such as corticobasal syndrome (CBS)) may improve diagnostic 
accuracy in vivo. 
 
Thalamic atrophy on MRI has been reported in cohorts with PSP relative to controls, but not 
in patients with PD, multisystem atrophy, CBS or dementia with Lewy bodies (DLB) (Cordato 
et al., 2005; Boxer et al., 2006; Watson et al., 2009; Messina et al., 2011); it should be noted 
that at least some DTI data has suggested different topographical involvement of the 
thalamus in CBS relative to PSP (Erbetta et al., 2009; Hess et al., 2014), but these studies are 
difficult to interpret. 
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A number of multimodal studies, both cross sectional and longitudinal, have reported 
involvement of particular thalamic nuclei in PSP. In a small cross sectional involving 14 
patients with ‘mild’ PSP and 14 healthy controls undergoing DTI and structural MRI, Padovani 
and colleagues (2006) reported thalamic atrophy involving the pulvinar, MD and AN 
bilaterally. In a multi-modal imaging study, 18 patients with probable PSP and 18 healthy 
controls underwent resting state fMRI, DTI and structural MRI; atrophy in the thalamus in the 
PSP group on MRI was reported, with reduced thalamic functional connectivity using fMRI, 
and DTI data implicating the VL (or motor) thalamus (Whitwell et al., 2011). Moreover, a PET 
and fMRI study in 16 patients with PSP suggested imbalance and falls correlated with thalamic 
dysfunction (Zwergal et al., 2011).  In a longitudinal study Whitwell and colleagues (2011), 16 
patients with ‘probable’ PSP had serial MRIs and clinical measures (including the PSP rating 
scale) at 6 months and 12 months of follow up; progressive thalamic atrophy over time was 
observed, however no correlation between thalamic atrophy and clinical measures was 
observed.  
 
Recent imaging data suggests there may be subtle nuances with regard to thalamic 
morphology in PD. Automated MRI data suggests left thalamic atrophy in PD with dementia 
compared to those with PD without dementia (Summerfield et al., 2005) and, furthermore, 
using spherical harmonic-based representations shape (but not volume) changes have been 
reported in the thalami in PD (McKeown et al., 2008). McKeown and colleagues (2008) 
suggest these shape differences may represent selective non-dopaminergic degeneration 
reported in the caudal IL nuclei of the thalamus in PD (Henderson et al., 2000), and that 
detecting these subtle changes may be limited by the resolution of MRI (McKeown et al., 
2008). 
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 Thalamic morphology in other neurodegenerative disorders 
Thalamic morphology has been investigated in a range of additional neurodegenerative 
disorders. Thalamic atrophy has been reported in patients with FTD compared with controls 
(Cardenas et al., 2007; Chow et al., 2008), however few studies have investigated whether 
these morphological features characterize the spectrum of FTDs, and whether thalamic 
morphology could assist in delineating various subtypes of this entity.  Rohrer and colleagues 
(2010) investigated 18 FTD patients who had antemortem MRI and postmortem confirmation 
of the TDP-43 subtype of FTD (positive immunoreactive inclusions), and using voxel-based 
morphometry reported that thalamic atrophy was useful in distinguishing FTD  TDP-43 type 3 
relative to types 1 and 2. Sharon and colleagues (2012) investigated patterns of brain atrophy 
in FTD patients who were carriers for chromosome open reading frame 72 (C9ORF72) 
expansions, and reported  greater thalamic atrophy (left>right) in carriers vs non carriers of 
this expansion.  
 
Thalamic atrophy on MRI has been reported in HD in the regions of MD, and the VL and IL 
nuclear groups bilaterally (Kassubek et al., 2005), consistent with postmortem findings 
(Heinsen et al., 1999). However, not all studies have reported thalamic atrophy in HD (Rosas 
et al., 2003). In a study with 44 HD patients (genetically confirmed) and 22 controls, using the 
Stroop color word and Digit Symbol tests, thalamic atrophy correlated with cognitive 
impairment but not motoric dysfunction in the early clinical stages of disease (Kassubek et al., 
2005). 
 
Thalamic morphology in multiple sclerosis 
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Thalamic atrophy appears to be an important feature in multiple sclerosis (MS) (for review 
see Minagar et al., 2013), and has been correlated post mortem with neuronal loss or altered 
cytoarchitecture in the thalamus, in particular in the MD and LGN (Cifelli et al., 2002; 
Verceillino et al., 2009). Thalamic atrophy has been reported in pediatric populations with MS 
(Kerbrat et al., 2012) and in adults with MS it is one of the earliest and most prominent 
features of subcortical grey matter pathology when patients present with clinically isolated 
syndrome (CIS) (Calabrese et al., 2011). Thalamic atrophy has been demonstrated in the 
spectrum of MS subtypes, and has been correlated with cognitive and functional impairment 
in MS (Houtchens et al., 2007; Mesaros et al., 2011; Batista et al., 2012). Multimodal 
longitudinal studies are warranted to elucidate the interplay of these findings in MS, and 
better define the utility of thalamic morphology in MS from a clinical perspective.  
 
TOWARDS THALAMIC ENDOPHENOTYPES AND BIOMARKERS IN NEURODEGENERATIVE 
DISEASE 
 
Towards endophenotypes and biomarkers 
The concept of intermediate phenotypes (or endophenotypes) has been described as, 
“measurable components unseen by the unaided eye along the pathway between disease 
and distal genotype” (Gottesman and Gould, 2003). This concept has already been applied to 
the morphology of subcortical structures in neurodegenerative disorders, such as the 
striatum (Looi and Walterfang, 2012). As outlined, there is a growing body of literature 
reporting thalamic involvement across a broad range of neurodegenerative disorders. Whilst 
further studies are required to ascertain whether genetic factors are associated with thalamic 
volume, there is evidence of distinct patterns of altered thalamic morphology in many 
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neurodegenerative disorders, and some evidence of an association between morphology and 
clinical features in those disorders. Should further evidence converge suggesting that 
distinctive genetic, morphological and clinical features are associated with the thalamus, this 
may provide a basis for thalamic endomorphotypes. Leading on from this argument, 
investigating thalamic morphology (as a measurable characteristic of disease) therefore has 
the potential to yield neuroimaging biomarkers in the neurodegenerative disorders.  
 
Potential utility of the thalamus as a morphological biomarker in neurodegenerative 
disease 
Neuroimaging investigation of subcortical structures is likely to contribute knowledge 
regarding how the morphology (shape and volume) of structures, such as the thalamus, 
underpins the neural circuits sub serving cognition, emotion, movement and behaviour. 
Utilizing thalamic morphology in neurodegenerative disorders has the potential not only to 
assist with diagnostic clarification, but is likely to contribute to better understanding the 
spatio-temporal course in various diseases. Further, characterizing the disease effects on this 
strategic ‘hub’ in the subcortical connectome will enable neuroimaging to be utilized to map 
the onset, progression and ultimately (when disease-modifying agents are accessible), 
response to treatment modalities in a form directly related to the neuropsychiatric symptoms 
and signs of disease (e.g., cognitive, emotional, behavioral and motor dysfunction). 
 
FUTURE DIRECTIONS AND CHALLENGES 
 
Further multifaceted studies will be required to advance the frontiers of knowledge of the 
subcortical connectome, in order better comprehend the complexity of brain disease on a 
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neural circuit basis. With regards to the thalamus as a central hub in the connectome, 
additional studies are required to better understand the genetic basis of thalamic 
morphology, including processes of neurodevelopment, neurogenesis and apoptosis in the 
thalamus. Neuroimaging studies will need to investigate associations of thalamic morphology 
with a range of clinical markers in health and disease, including neurocognitive function, 
emotion and behavior, and motoric function. Longitudinal studies are warranted to ascertain 
the temporal and spatial effects of disease processes on thalamic morphology, particularly in 
patient cohorts with well-established genetic vulnerabilities.  
 
Given the challenges of thalamic boundary definition and variability of methods employed 
between neuroimaging studies, widely available and validated protocols for segmentation of 
the thalamus on MRI using sophisticated imaging techniques and brain analysis software will 
need to be established in order for morphological studies to progress and be reproducible. 
These protocols may well lead to more reliable automated segmentation techniques, in 
essence rendering automated techniques redundant in the future. Multimodal neuroimaging 
approaches will be essential (such as combining structural MRI, with DTI and shape analysis) 
in order to fully appreciate the impact of disease processes on different thalamic nuclei, and 
(through the well-established topographical relationships of the thalamus) better appreciate 
the diseased brain circuitry.  
 
In the Odyssey, Book 19 comes an early usage of thalamos: “ἡ δ' ἴεν ἐκ θαλάμοιο περίφρων 
Πηνελόπεια, Ἀρτέμιδι ἰκέλη ἠὲ χρυσέῃ Ἀφροδίτῃ”; translated by Fagles (1996), “Now down 
from her chamber came reserved Penelope, looking for all the world like Artemis or golden 
Aphrodite”). Emerging from the chamber of thalamic morphology we may come upon the 
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vista of neural circuit dysfunction in neurodegenerative disorders and, given its particular 
relationship with cortex, perhaps it may be one of the most panoramic. 
  
29 
 
ACKNOWLEGEMENTS 
BDP conceived and wrote the first draft of the manuscript, and is guarantor for this paper; 
JCLL co-conceived the work as the research network coordinator. All authors contributed to 
the final version of the manuscript. Given the restrictions on the number of references, only 
limited citations are provided on the section Basic and Clinical Neuroanatomy of the 
Thalamus. 
 
This research received no specific grant from any funding agency in the public, commercial or 
not-for-profit sectors. BDP’s academic time is supported by the School of Medicine Fremantle, 
The University of Notre Dame Australia, and JCLL’s academic time by the Research Centre for 
the Neurosciences of Ageing, Academic Unit of Psychiatry and Addiction Medicine, Australian 
National University Medical School.  
 
Declaration of conflicting of interests 
The authors declare that there is no conflict of interest. The authors alone are responsible for 
the content and writing of the paper. 
  
30 
 
 REFERENCES 
Adriano F, Spoletini I, Caltagirone C, Spalletta G (2010) Updated meta-analyses reveal 
thalamus volume reduction in patients with first-episode and chronic schizophrenia. 
Schizophrenia Research 123: 1-14.  
 
Aguzzi A, Polymenidou M (2004) Mammalian prion biology: one century of evolving concepts. 
Cell 116: 313-327. 
 
Andreasen NC, Arndt S, Swayze V, et al. (1994) Thalamic abnormalities in schizophrenia 
visualized through magnetic resonance image averaging. Science 266: 294-298. 
 
Andreasen NC, Pearson R (2008) The role fo the cerebellum in schizophrenia. Biological 
Psychiatry 64: 81-88. 
 
Batista S, Zivadinov R, Hoogs M, et al. (2012) Basal ganglia, thalamus and neocortical atrophy 
predicting slowed cognitive processing in multiple sclerosis. Journal of Neurology 259: 139-
146. 
 
Blackshaw S, Scholpp S, Placzek M, Ingraham H, Simerly R, Shimogori T (2010) Molecular 
pathways controlling development of thalamus and hypothalamus: from neural specification 
to circuit formation. Journal of Neuroscience 30: 14925-14930. 
 
31 
 
Bosman LWJ, Houweling AR, Owens CB, et al. (2011) Anatomical pathways involved in 
generating and sensing rhythmic whisker movements. Frontiers in Integrative Neuroscience 5: 
53. 
 
Bourassa J, Pinault D, Deschenes M (1995) Corticothalamic projections from the cortical barrel 
field to the somatosensory thalamus in rats: a single-fibre study using biocytin as an 
anterograde tracer. European Journal of Neuroscience 7: 19-30. 
 
Boxer AL, Geschwind MD, Belfor N, et al. (2006) Patterns of brain atrophy that differentiate 
corticobasal degeneration syndrome from progressive supranuclear palsy. Archives of 
Neurology 63: 81-86. 
 
Braak H, Braak E (1991) Alzheimer’s disease effects limbic nuclei of the thalamus. Acta 
Neuropathologica 81: 261-268.  
 
Braak H, Rub U, Gai WP, Del Tredici K (2003) Idiopathic Parkinson’s disease: possible routes 
by which vulnerable neuronal types may be subject to neuroinvasion by an unknown 
pathogen. Journal of Neural Transmission 110: 517-536.  
 
Brucato N, Guadalupe T, Franke B, Fisher SE, Francks C (2015) A schizophrenia-associated HLA 
locus affects thalamic volume and asymmetry. Brain Behavior and Immunology DOI: 
10.1016/j.bbi.2015.02.021.  
 
32 
 
Brundin P, Melki R, Kopito R (2010) Prion-like transmission of protein aggregates in 
neurodegenerative disease. Nature Reviews Molecular Cell Biology 11: 301-307.  
 
Bulfone A, Puelles L, Porteus MH, Frohman MA, Martin GR, Rubenstein JL (1993) Spatially 
restricted expression of Dlx-1, Dlx-2 (Tes-1), Gbx-2, and Wnt-3 in the embryonic day 12.5 
mouse forebrain defines potential transverse and longitudinal segmental boundaries. Journal 
of Neuroscience 13: 3155-3172. 
 
Bullmore E, Sporns O (2009) Complex brain networks: graph theoretical analysis of structural 
and functional system. Nature Reviews Neuroscience 10: 186-198.  
 
Byne W, Hazlett EA, Buchsbaum MS, Kemether E (2009) The thalamus and schizophrenia: 
current status of research. Acta Neuropathologica 117: 347-368.  
 
Calabrese M, Rinaldi F, Mattisti I, et al. (2011) The predictive value of gray matter atrophy in 
clinically isolated syndromes. Neurology 77: 257-263.  
 
Callen DJ, Black SE, Gao F, Caldwell CB, Szalai JP (2001) Beyond the hippocampus: MRI 
volumetry confirms widespread limbic atrophy in AD. Neurology 57: 1669-1674.  
 
Cardenas VA, Boxer AL, Chao LL, et al. (2007) Deformation-based morphometry reveals brain 
atrophy in frontotemporal dementia. Archives of Neurology 64: 873-877.  
 
33 
 
Chow TW, Izenberg A, Binns MA, et al. (2008) Magnetic resonance imaging in frontotemporal 
dementia shows subcortical atrophy. Dementia and Geriatric Cognitive. Disorders 26: 79-88.  
 
Cifelli A, Arridge M, Jezzard P, Esiri MM, Palace J, Matthews PM (2002) Thalamic 
neurodegeneration in multiple sclerosis. Annals of Neurology 52: 650-653.  
 
Cordato NJ, Duggins AJ, Halliday GM, Morris JG, Pantelis C (2005) Clinical deficits correlate 
with regional cerebral atrophy in progressive supranuclear palsy. Brain 128: 1259-1266. 
 
Crick F (1984) Function of the thalamic reticular complex: The searchlight hypothesis. 
Proceedings of the National Academy of Science USA 81: 4586-4590. 
 
Cummings JL (1993) Frontal subcortical circuits and human behavior. Archives of Neurology 
5: 873-880.  
 
Darien-Smith C, Tan A, Edwards S (1999) Comparing thalamocortical and corticothalamics 
microstructure and spatial reciprocity in the macaque ventral posterolateral nucleus (VPLc) 
and medial pulvinar. Journal of Comparative Neurology 410: 211-234.  
 
de Jong LW, van der Hiele K, Veer IM, et al. (2008) Strongly reduced volumes of putamen and 
thalamus in Alzheimer's disease: an MRI study. Brain 131: 3277-3285.  
 
34 
 
Deng YP, Albin RL, Penney JB, Young AB, Anderson KD, Reiner A (2004) Differential loss of 
striatal projection systems in Huntington’s disease: a quantitative immunohistochemical 
study. Journal of Chemical Neuroanatomy 27: 143-164.  
 
Du MY, Wu QZ, Yue Q et al. (2012) Voxelwise meta-analysis of gray matter reduction in major 
depressive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 36: 11-
16.  
 
Erbetta A, Mandelli ML, Savoiardo M, et al. (2009) Diffusion Tensor Imaging shows different 
topographic involvement of the thalamus in progressive supranuclear palsy and corticobasal 
degeneration. American Journal of Neuroradiology 30: 1482-1487. 
 
Fagles, R., 1996. Homer: The Odyssey. Penguin Books Australia Ltd, Ringwood Australia.  
 
Gottesman II, Gould TD (2003) The endophenotype concept in psychiatry: etymology and 
strategic intentions. American Journal of Psychiatry 160: 636-645. 
 
Guillery RW (1995) Anatomical evidence concerning the role of the thalamus in corticocortical 
communication: a brief review. Journal of Anatomy 187: 583-592. 
 
Haber S, Calzavara R (2009) The cortico-basal ganglia integrative network: The role of the 
thalamus. Brain Research Bulletin 78: 69-74. 
 
35 
 
Hallahan B, Newell J, Soares JC, et al. (2010) Structural magnetic resonance imaging in bipolar 
disorder: an international collaborative mega-analysis of individual adult patient data. 
Biological Psychiatry 69: 326-35.  
 
Halliday GM, Macdonald V, Henderson JM (2005) A comparison of degeneration in motor 
thalamus and cortex between progressive supranuclear palsy and Parkinson's disease. 
Brain 128: 2272-2280. 
 
Heinsen H, Rub U, Bauer M et al. (1999) Nerve cell loss in the thalamic mediodorsal nucleus 
in Huntington’s disease. Acta Neuropathologica 97: 613-622.  
 
Henderson JM, Carpenter K, Cartwright H, Halliday GM (2000) Loss of thalamic intralaminar 
nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic 
implications. Brain 123: 1410-1421. 
 
Hess CP, Christine CW, Apple AC, Dillon WP, Aminoff MJ (2014) Changes in the thalamus in 
atypical parkinsonism detected using shape analysis and diffusor tensor imaging. American 
Journal of Neuroradiology 35: 897-903.  
 
Houtchens MK, Benedict RH, Killiany R, et al. (2007) Thalamic atrophy and cognition in 
multiple sclerosis. Neurology 69: 1213-1223. 
 
36 
 
Jakab A, Blanc R, Berenyi EL, Szekely G (2012) Generation of individualized thalamus target 
maps using statistical shape models and thalamocortical tractography. American Journal of 
Neuroradioogy 33: 2110-2116. 
 
Jindahra P, Petrie A, Plant GT (2012) The time course of retrograde trans-synaptic 
degeneration following occipital lobe damage in humans. Brain 135: 534-541. 
 
Jones EG (2007) The Thalamus, second ed. Cambridge Univeristy Press, Cambridge UK. 
 
Kaas JH, Hall WC, Killackey HP, Diamond IT (1972) Visual cortex of the tree shrew (Tupaia glis): 
architectonic subdivisions and representations of the visual field. Brain Research 42, 491-496.  
 
Kassubek J, Juengling FD, Ecker D, Landwehrmeyer GB (2005) Thalamic atrophy in 
Huntington's Disease co-varies with cognitive performance: a morphometric MRI analysis. 
Cerebral Cortex 15: 846-853.  
 
Kerbrat A, Aubert-Broche B, Fonov V et al. (2012) Reduced head and brain size for age and 
disproportionately smaller thalami in child-onset MS. Neurology 78: 194-201. 
 
Knight WD, Okello AA, Ryan NS et al. (2011) Carbon-11-Pittsburgh compound B positron 
emission tomography imaging of amyloid deposition in presenilin 1 mutation 
carriers. Brain 134: 293-300. 
 
37 
 
Kolmac CI, Power BD, Mitrofanis J (2000) Dorsal thalamic connections of the ventral lateral 
geniculate nucleus. Journal of Neurocytology 29: 31-41.  
 
Konarski JZ, McIntyre RS, Grupp LA, Kennedy SH (2005) Is the cerebellum relevant in the 
circuitry of neuropsychiatric disorders? Journal of Psychiatry and Neuroscience 30: 178-186. 
 
Kril JJ, Halliday GM (2011) Pathological staging of frontotemporal lobar degeneration. Journal 
of Molecular Neuroscience 45: 379-383.  
 
Lee GJ, Lu PH, Medina LD, Rodriguez-Agudelo Y, Melchor S, Coppola G (2013) Regional brain 
volume differences in symptomatic and presymptomatic carriers of familial Alzheimer’s 
disease mutations. Journal of Neurology, Neurosurgery and Psychiatry 84: 154-162.  
 
Looi JCL, Tatham V, Kumar R et al. (2009) Caudate nucleus volumes in stroke and vascular 
dementia. Psychiatry Research 174: 67-75 
 
Looi JCL, Walterfang M (2012) Striatal morphology as a biomarker in neurodegenerative 
disease. Molecular Psychiatry 18: 417-424. 
 
Looi JCL, Walterfang M, Velakoulis D, Macfarlane MD, Svensson L, Wahlund LO (2012) 
Frontotemporal Dementia as a frontostriatal disorder: neostriatal morphology as a biomarker 
and structural basis for an endophenotype. Australian and New Zealand Journal of Psychiatry 
46: 422-434. 
 
38 
 
Looi JCL, Walterfang M, Nilsson C, et al. (2014) The subcortical connectome: hubs, spokes and 
the space between. Australian and New Zealand Journal of Psychiatry 48: 306-309. 
 
Madsen SK, Ho AJ, Hua X, et al. (2010) 3D maps localize caudate nucleus atrophy in 400 AD, 
MCI, and healthy elderly subjects. Neurobiology of Aging 31: 1312-1325. 
 
McKeown MJ, Uthama A, Abugharbieh R, Palmer S, Lewis M, Huang X (2008) Shape (but not 
volume) changes in the thalami in Parkinson disease. BioMed Central Neurology 8, 8 
DOI:10.1186/1471-2377-8-8.  
 
Mesaros S, Rocca MA, Pagani E, et al. (2011) Thalamic damage predicts the evolution of 
primary-progressive multiple sclerosis at 5 years. American Journal of Neuroradiology 32: 
1016-1020. 
 
Messina D, Cerasa A, Condino F et al. (2011) Patterns of brain atrophy in Parkinson’s disease, 
progressive supranuclear palsy and multiple system atrophy. Parkinsonism and Related 
Disorders 17: 172-176. 
 
Middleton FA, Strick PL (1994) Anatomical evidence for cerebellar and basal ganglia 
involvement in higher cognitive function. Science 266: 458-461.  
 
Minagar A, Barnett MH, Benedict RHB, et al. (2013) The thalamus and multiple sclerosis. 
Neurology 80: 210-219. 
 
39 
 
Mitrofanis J (2005) Some uncertainty for the “zone of uncertainty”? Exploring the function of 
the zona incerta. Neuroscience 130: 1-15.  
 
Padovani A, Borroni B, Brambati SM, et al. (2006) Diffusion tensor imaging and voxel based 
morphometry study in early progressive supranuclear palsy. Journal of Neurology, 
Neurosurgery and Psychiatry 77: 457-463. 
 
Palop JJ, Mucke L, (2009) Synaptic depression and aberrent excitatory network activity and 
Alzheimer’s disease: two faces of the same coin? Neuromolecular Medicine 12: 48-55. 
 
Polymenidou M, Cleveland DW (2012) Prion-like spread of protein aggregates in 
neurodegeneration. Journal of Experimental Medicine 209: 889-893. 
 
Portas CM, Goldstein JM, Shenton ME, et al. (1998) Volumetric evaluation of the thalamus in 
schizophrenic male patients using magnetic resonance imaging. Biological Psychiatry 43: 649-
659.  
 
Power BD, Kolmac CI, Mitrofanis J (1999) Evidence for a large projection from the zona incerta 
to the dorsal thalamus. Journal of Comparative Neurology 404: 554-565. 
 
Power BD, Wilkes FA, Santillo A, et al. (2015).Validation of a protocol for manual segmentation 
of the thalamus on magnetic resonance imaging scans. Psychiatry Research-Neuroimaging. 
doi: 10.1016/j.pscychresns.2015.02.001. 
 
40 
 
Power BD, Looi JCL (2014) The thalamus as a putative biomarker in neuropsychiatry. OA 
Neurosciences 2: 6. 
 
Prevosto V, Sommer MA (2013) Cognitive control of movement via the cerebellar-recipient 
thalamus. Frontiers in Systems. Neuroscience 7: 56. 
 
Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216: 136-
144.  
 
Puelles L, Rubenstein JL (2003) Forebrain gene expression domains and the evolving 
prosomeric model. Trends in Neuroscience 26: 469-476. 
 
Raj A, Kuceyeski A, Weiner MA (2012) Network diffusion model of disease progression in 
dementia. Neuron 73: 1204-1215. 
 
Rohrer JD, Geser F, Zhou J, et al. (2010) TDP-43 subtypes are associated with distinct atrophy 
patterns in frontotemporal dementia. Neurology 75: 2204-2211. 
 
Rosas HD, Koroshetz WJ, Chen YI, et al. (2003) Evidence for more widespread cerebral 
pathology in early HD: an MRI-based morphometric analysis. Neurology 60: 1615-1620.  
 
Ryan NS, Keihaninejad S, Shakespeare TJ, et al. (2013) Magnetic resonance imaging evidence 
for presymptomatic change in thalamus and caudate in familial Alzheimer's disease. Brain 
136: 1399-1414.  
41 
 
 Schmahmann JD (2004) Disorders of the cerebellum, dysmetria of thought, and the cerebellar 
cognitive affective syndrome. Journal of Neuropsychiatry and Clinical Neuroscience 16: 367-
378. 
 
Scholpp S, Delogu A, Gilthorpe J, Peukert D, Schindler S, Lumsden A (2009) Her6 regulates the 
neurogenetic gradient and neuronal identity in the thalamus. Proceedings of the National 
Academy of Science USA 106: 19895-19900. 
 
Seeley WW, Crawford RK, Zhou J, Miller BL, Greicius MD (2009) Neurodegenerative diseases 
target large-scale human brain networks. Neuron 62: 42-52. 
 
Sharon JS, Takada LT, Rankin KP, et al. (2012) Frontotemporal dementia due to C9ORF72 
mutations Clinical and imaging features. Neurology 79: 1002-1011. 
 
Sherman SM, Guillery RW (2006) Exploring the thalamus and its role in cortical function. 
second ed. MIT Press, Cambridge USA. 
 
Sillito AM, Jones HE, Gerstein GL, West DC (1994) Feature-linked synchronisation of thalamic 
relay cell firing induced by feedback from the visual cortex. Nature 369: 479-482.  
 
Spinks R, Magnotta VA, Andreasen NC, et al. (2002) Manual and automated measurement of 
the whole thalamus and mediodorsal nucleus using magnetic resonance imaging. 
Neuroimage 17: 631-642.  
42 
 
 Steriade M, Deschenes M (1984) The thalamus as a neuronal oscillator. Brain Research 
Reviews 8: 1-63. 
 
Styner M, Oguz I, Xu S, Brechbühler C, et al. (2006) Framework for the Statistical Shape 
Analysis of Brain Structures using SPHARM-PDM. Insight Journal 1071: 242-250. 
 
Summerfield C, Junqué C, Tolosa E, et al. (2005) Structural brain changes in Parkinson disease 
with dementia voxel-based morphometry study. Archives of Neurology 62: 281-285. 
 
Tekin S, Cummings JL, (2002) Frontal-subcortical neuronal circuits and clinical 
neuropsychiatry: an update. Journal of Psychosomatic Research. 53: 647-654. 
 
Uylings HB, Amunts K, Mohlberg H, Pool CW, Zilles K, Smeets WJ (2008) 3D Probabilistic map 
of cytoarchitectonically defined human thalamic nuclei in standard MRI. Frontiers in 
Neuroinformatics 01/2008; DOI:10.3389/conf.neuro.11.2008.01.057.  
 
van der Werf YD, Tisser DJ, Visser PJ, et al. (2001) Thalamic volume predicts performance on 
tests of cognitive speed and decreases in healthy aging. A magnetic resonance imaging-based 
volumetric analysis. Cognitive Brain Research 11: 377-385. 
 
Vercellino M, Masera S, Lorenzatti M, et al. (2009) Demyelination, inflammation, and 
neurodegeneration in multiple sclerosis deep gray matter. Journal of Neuropathology and 
Experimental Neurology 68: 489-502. 
43 
 
 Volkmann J, Daniels C, Witt K (2010) Neuropsychiatric effects of subthalamic 
neurostimulation in Parkinson disease. Nature Reviews Neurology 6: 487-498.  
 
Warren JD, Rohrer JD, Schott JM, Fox NC, Hardy J, Rosser MN (2013) Molecular nexopathies: 
a new paradigm of neurodegenerative disease. Trends in Neuroscience 36: 561-569. 
 
Watson R, Blamire AM, O’Brien JT (2009) Magnetic resonance imaging in Lewy Body 
dementias. Dementia and Geriatric Cognitive Disorders 28: 493-506. 
 
Walker LC, LeVine H (2012) Corruption and spread of pathogenic proteins in 
neurodegenerative disease. Journal of Biological Chemistry 287: 33109-33115.  
 
Whitwell JL, Avula R, Master A et al. (2011) Disrupted thalamocortical connectivity in PSP: a 
resting state fMRI, DTI, VBM study. Parkinsonism and Related Disorders 17: 599-605.  
 
Whitwell JL, Xu J, Mandrekar JN, Gunter JL, Jack CR, Josephs KA (2012) Rates of brain atrophy 
and clinical decline over 6 and 12-month intervals in PSP: determining sample size 
for treatment trials. Parkinsonism and Related Disorders 18: 252-256. 
 
Xuereb JH, Perry RH, Candy JM, Marshall E, Bonham JR (1991) Nerve cell loss in the thalamus 
in Alzheimer’s disease and Parkinson’s disease. Brain 114: 1363-1379.  
 
44 
 
Zarei M., Patenaude B, Damoiseaux J, et al. (2010) Combining shape and connectivity analysis: 
an MRI study of thalamic degeneration in Alzheimer's disease. Neuroimage 49: 1-8. 
 
Zhou J, Gennatas ED, Kramer JH, Miller BL, Seeley WW (2012) Predicting regional 
neurodegeneration from the healthy brain functional connectome. Neuron 73: 1216-1227. 
 
Zwergal A, La Fougere C, Lorenzl S et al. (2011) Postural imbalance and falls in PSP correlate 
with functional pathology of the thalamus. Neurology 77: 101-109. 
  
45 
 
 LIST OF FIGURES AND TABLES  
 
Figure 1. Figure showing sections through the thalamus.  
 
(A) and (B) are MRI T1 weighted images of the same section of human thalamus (traced in 
red), with intensity settings inverted (using ANALYZE 11.0 software); images provided by the 
authors.  
 
(C) is a Nissl stained coronal section through Macaca Mulatta thalamus; abbreviations of 
relevant thalamic structures labelled: 3V=third ventricle; CL=central lateral nucleus; 
CM=centre median nucleus; LD=lateral dorsal nucleus; LP=lateral posterior nucleus; 
MD=medial dorsal nucleus; Pa=paratenial nuclues; Pf=parafasciular nucleus; R=reticular 
thalamic nucleus; VM=ventral medial nucleus; VPL=ventral posterolateral nucleus; 
VPM=ventral posteromedial nucleus. The image in (C) is adapted and sourced from 
BrainMaps.org, available via open access from http://brainmaps.org/ajax-viewer.jpg; (where 
additional abbreviations can be found), with license: 
http://creativecommons.org/licenses/by/3.0. 
 
Figure 2. Schematic diagram of the thalamus (right) showing subdivisions and nuclei 
 
From Wikimedia Commons, reproduced via open access (Creative Commons); image available 
at http://commons.wikimedia.org/wiki/User:Rocket000/SVGs/Biology/Human_anatomy. 
License: http://creativecommons.org/licenses/by-sa/3.0/legalcode. 
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 Figure 3. Schematic diagram showing first order and higher order relays 
 
A first order thalamic relay represents the first relay of peripheral or subcortical information 
of a particular type to a first order or primary cortical area. A higher order relay relays 
information from layer 5 of one cortical area to another cortical area; this can be between 
first order and higher order cortical area or between two higher order cortical areas. The 
difference is the driver input, which is subcortical for a first order relay and from layer 5 of 
cortex for a higher order relay. Abbreviations: FO=first order; HO=higher order; LGN=lateral 
geniculate nucleus; MGNd and MGNv=dorsal and ventral portions of the medial geniculate 
nucleus; PO=posterior nucleus; Pul=pulvinar; TRN=thalamic reticular nucleus; VP=ventral 
posterior nucleus.  
 
From Sherman (2006), reprinted through open access from Scholarpedia: Thalamus, 
1(9):1583 (http://www.scholarpedia.org/article/Thalamus). Link to the license: 
http://creativecommons.org/licenses/by-nc-sa/3.0/legalcode. 
 
Figure 4. Maps in the thalamus.  
 
Schematic representation of the trigemino-thalamo-cortical pathways. The arrowheads 
indicate the termination areas of the axons. Note that (in the cerebral cortex) the 
postsynaptic cells may have their somata in other layers. The line thickness indicates the 
relative importance of the pathways. The barreloids in VPM are indicated in an oblique 
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coronal slice, the barrelettes of the trigeminal nuclei in coronal slices. D = dorsal; L=lateral; 
LD=laterodorsal nucleus of the thalamus; Pom=medial posterior nucleus of the thalamus; 
PrV=primary trigeminal nucleus; R=rostral; SpVic=caudal part of spinal trigeminal nucleus pars 
interpolaris; SpVio=oral part of SpVi; SpVo=spinal trigeminal nucleus pars oralis; 
VPMdm=dorsomedial part of the ventroposterior medial nucleus of the thalamus; 
VPMh=“head” area of VPM; VPMvl=ventrolateral part of VPM; wM1=whisker motor cortex; 
wS1=whisker part of primary sensorimotor cortex; wS2=whisker part of secondary 
sensorimotor cortex. 
From Bosman and colleagues (2011), reproduced from Frontiers via open access; figure 
available from http://journal.frontiersin.org/Journal/10.3389/fnint.2011.00053/full. 
 
Figure 5. Fronto-subcortical loops involving the thalamus 
 
Schematic diagram illustrating the organisation of the fronto-subcortical loops within human 
brain. (a) Motor loops; (b) Associative loops; and (c) Limbic loops. Abbreviations: GPi=globus 
pallidus internal; GPe=globus pallidus external; STN=subthalamic nucleus. 
 
From Volkman and colleagues (2010), reprinted with permission from Nature Publishing 
Group: Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease. 
Nature Reviews Neurology 6, 487-498. 
 
Figure 6. Cerebellothalamocortical circuits 
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A) Lateral view of the rhesus monkey brain with hemispheres separated to expose mesial wall 
on top. Arrows schematically represent cerebello-cortical pathways relayed via cerebellar 
territories in lateral (left, violet) and central thalamus(right, green). (B) Two representative 
sections of the thalamus of Macaca mulatta, viewed from a lateral anterior perspective. 
Cerebellar domains in lateral and central thalamus are presented in violet and green, 
respectively. (C) Same sections as (B), but illustrating effector-related functional, as opposed 
to hodological, compartments. Hatching shows the rough somatotopic locations of regions 
related to arm (vertical)and eye (diagonal) movements. Abbreviations: DN=dentate nucleus; 
MIP=medial intraparietal area; LIP=lateral intraparietal area; M1=primary motor cortex; 
PMd=dorsal premotor cortex; PMv=ventral premotor cortex; FEF=frontal eye fields; 
PFc=prefrontal cortex; SMA=supplementary motor area; pre-SMA= pre-supplementary motor 
area; VLo=ventrolateral nucleus pars oralis;VPLo= ventroposterolateral nucleus pars oralis; 
MD=mediodorsal nucleus; VLc=ventrolateral nucleus pars caudalis; X= nucleus X of the 
thalamus.  
 
From Prevosto and Summer (2013), reprinted via open access from Frontiers: Cognitive 
control of movement via the cerebellar-recipient thalamus. Frontiers in Systems 
Neuroscience 7, 56. 
 
Figure 7. Conceptualization of neurodegenerative disorders on a neural circuit basis 
 
A. Intracellular protein aggregates can be released from neurons by exocytosis or cell death. 
The aggregates are taken up by, for example, adjacent neuronal cell bodies and are either 
retained in the cell soma (local spread of pathology) or transported anterogradely by axons. 
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Alternatively, they are taken up by axon terminals and transported retrogradely to the cell 
soma. The protein aggregates can spread between brain regions by axonal transport. B-D. 
Three drawings propose principles for how neuropathological changes in Parkinson's, 
Alzheimer's and Huntington's diseases spread spatiotemporally during disease progression. 
The earlier the neuropathology develops in a given brain region, the darker the shading in the 
diagram. As only one view (mid-sagittal for Parkinson's and Alzheimer's diseases; lateral for 
Huntington's disease) of the brain is depicted for each disorder, not all relevant anatomical 
structures and details of the spreading patterns (indicated by arrows) are presented.  
 
From Brundin and colleagues (2010), reproduced with permission from Nature Publishing 
Group: Prion-like transmission of protein aggregates in neurodegenerative disease. Nature 
Reviews Molecular Cell Biology 11, 301-307 (Figure 3). 
 
Table 1 Classification, connections and functions of the dorsal thalamic nuclei  
 
Adapted from:  Power and Looi (2015). 
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Abbreviations 
 
AD: Alzheimer’s dementia 
AN: anterior nucleus of the thalamus 
CAMCOG-R: Cambridge Cognitive Assessment - Revised 
CBS: corticobasal syndrome 
CJD: Creutzfeldt-Jakob disease  
CL: central lateral nucleus of the thalamus 
CM: centre median nucleus of the thalamus 
DLB: Dementia with Lewy bodies 
DTI: diffusion tensor imaging 
DWI: Diffusion-weighted imaging  
eml: external medullary lamina 
EPSP: excitatory postsynaptic potentials  
FO: first order thalamic nuclei 
FGF: fibroblast growth factor 
fMRI: functional magnetic resonance imaging 
FLAIR: fluid attenuation inversion recovery 
FTD: frontotemporal dementia 
GABA: γ-aminobutyric acid 
HD: Huntington’s disease 
HO: higher order thalamic nuclei 
IML: internal medullary lamina 
IL: intralaminar nuclei of the thalamus 
LD: lateral dorsal nucleus of the thalamus 
LGN: lateral geniculate complex of the thalamus 
MD: medial dorsal nucleus of the thalamus 
MGN: medial geniculate nucleus of the thalamus 
ML: midline nuclei of the thalamus 
MMSE: mini mental state examination 
MS: multiple sclerosis 
MRI: magnetic resonance imaging 
NGN1: Neurogenin1  
PD: Parkinson’s disease 
PET: positron emission tomography 
Pf: parafascicular thalamic nucleus 
PNFA: progressive nonfluent aphasia  
PSP: progressive supranuclear palsy  
Pt: paratenial thalamic nucleus 
Re: reunions thalamic nucleus 
RTN: thalamic reticular nucleus  
SHH: Sonic hedgehog  
SPECT: single photon emission computed tomography 
SPHARM-PDM: spherical harmonic point distribution method  
STN: subthalamic nucleus 
VA: ventral anterior nucleus of the thalamus 
VL: ventral lateral nucleus of the thalamus 
VP: ventral posterior nucleus of the thalamus 
VPL: ventral posterolateral nucleus of the thalamus 
VPM: ventral posteromedial nucleus of the thalamus 
ZI: the zona incerta 
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Figure 1. Figure showing sections through the thalamus.  
 
(A) and (B) are MRI T1 weighted images of the same section of human thalamus (traced in red), with 
intensity settings inverted (using ANALYZE 11.0 software); images provided by the authors.  
 
(C) is a Nissl stained coronal section through Macaca Mulatta thalamus; abbreviations of relevant 
thalamic structures labelled: 3V=third ventricle; CL=central lateral nucleus; CM=centre median 
nucleus; LD=lateral dorsal nucleus; LP=lateral posterior nucleus; MD=medial dorsal nucleus; 
Pa=paratenial nuclues; Pf=parafasciular nucleus; R=reticular thalamic nucleus; VM=ventral medial 
nucleus; VPL=ventral posterolateral nucleus; VPM=ventral posteromedial nucleus. The image in (C) is 
adapted and sourced from BrainMaps.org, available via open access from http://brainmaps.org/ajax-
viewer.jpg; (where additional abbreviations can be found), with license: 
http://creativecommons.org/licenses/by/3.0. 
 
Figure 2. Schematic diagram of the thalamus (right) showing subdivisions and nuclei 
 
From Wikimedia Commons, reproduced via open access (Creative Commons); image available at 
http://commons.wikimedia.org/wiki/User:Rocket000/SVGs/Biology/Human_anatomy. License: 
http://creativecommons.org/licenses/by-sa/3.0/legalcode. 
 
Figure 3. Schematic diagram showing first order and higher order relays 
 
A first order thalamic relay represents the first relay of peripheral or subcortical information of a 
particular type to a first order or primary cortical area. A higher order relay relays information from 
layer 5 of one cortical area to another cortical area; this can be between first order and higher order 
cortical area or between two higher order cortical areas. The difference is the driver input, which is 
subcortical for a first order relay and from layer 5 of cortex for a higher order relay. Abbreviations: 
FO=first order; HO=higher order; LGN=lateral geniculate nucleus; MGNd and MGNv=dorsal and 
ventral portions of the medial geniculate nucleus; PO=posterior nucleus; Pul=pulvinar; TRN=thalamic 
reticular nucleus; VP=ventral posterior nucleus.  
 
From Sherman (2006), reprinted through open access from Scholarpedia: Thalamus, 1(9):1583 
(http://www.scholarpedia.org/article/Thalamus). Link to the license: 
http://creativecommons.org/licenses/by-nc-sa/3.0/legalcode. 
 
Figure 4. Maps in the thalamus 
 
Schematic representation of the trigemino-thalamo-cortical pathways. The arrowheads indicate the 
termination areas of the axons. Note that (in the cerebral cortex) the postsynaptic cells may have their 
somata in other layers. The line thickness indicates the relative importance of the pathways. The 
barreloids in VPM are indicated in an oblique coronal slice, the barrelettes of the trigeminal nuclei in 
coronal slices. D = dorsal; L=lateral; LD=laterodorsal nucleus of the thalamus; Pom=medial posterior 
nucleus of the thalamus; PrV=primary trigeminal nucleus; R=rostral; SpVic=caudal part of spinal 
trigeminal nucleus pars interpolaris; SpVio=oral part of SpVi; SpVo=spinal trigeminal nucleus pars 
oralis; VPMdm=dorsomedial part of the ventroposterior medial nucleus of the thalamus; 
VPMh=“head” area of VPM; VPMvl=ventrolateral part of VPM; wM1=whisker motor cortex; 
wS1=whisker part of primary sensorimotor cortex; wS2=whisker part of secondary sensorimotor 
cortex. 
From Bosman and colleagues (2011), reproduced from Frontiers via open access; figure available from 
http://journal.frontiersin.org/Journal/10.3389/fnint.2011.00053/full. 
 
Figure 5. Fronto-subcortical loops involving the thalamus 
 
Schematic diagram illustrating the organisation of the fronto-subcortical loops within human brain. 
(a) Motor loops; (b) Associative loops; and (c) Limbic loops. Abbreviations: GPi=globus pallidus 
internal; GPe=globus pallidus external; STN=subthalamic nucleus. 
 
From Volkman and colleagues (2010), reprinted with permission from Nature Publishing Group: 
Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease. Nature Reviews 
Neurology 6, 487-498. 
 
Figure 6. Cerebellothalamocortical circuits 
 
A) Lateral view of the rhesus monkey brain with hemispheres separated to expose mesial wall on top. 
Arrows schematically represent cerebello-cortical pathways relayed via cerebellar territories in lateral 
(left, violet) and central thalamus(right, green). (B) Two representative sections of the thalamus of 
Macaca mulatta, viewed from a lateral anterior perspective. Cerebellar domains in lateral and central 
thalamus are presented in violet and green, respectively. (C) Same sections as (B), but illustrating 
effector-related functional, as opposed to hodological, compartments. Hatching shows the rough 
somatotopic locations of regions related to arm (vertical)and eye (diagonal) movements. 
Abbreviations: DN=dentate nucleus; MIP=medial intraparietal area; LIP=lateral intraparietal area; 
M1=primary motor cortex; PMd=dorsal premotor cortex; PMv=ventral premotor cortex; FEF=frontal 
eye fields; PFc=prefrontal cortex; SMA=supplementary motor area; pre-SMA= pre-supplementary 
motor area; VLo=ventrolateral nucleus pars oralis;VPLo= ventroposterolateral nucleus pars oralis; 
MD=mediodorsal nucleus; VLc=ventrolateral nucleus pars caudalis; X= nucleus X of the thalamus.  
 
From Prevosto and Summer (2013), reprinted via open access from Frontiers: Cognitive control of 
movement via the cerebellar-recipient thalamus. Frontiers in Systems Neuroscience 7, 56. 
 
Figure 7. Conceptualization of neurodegenerative disorders on a neural circuit basis 
 
A. Intracellular protein aggregates can be released from neurons by exocytosis or cell death. The 
aggregates are taken up by, for example, adjacent neuronal cell bodies and are either retained in the 
cell soma (local spread of pathology) or transported anterogradely by axons. Alternatively, they are 
taken up by axon terminals and transported retrogradely to the cell soma. The protein aggregates can 
spread between brain regions by axonal transport. B-D. Three drawings propose principles for how 
neuropathological changes in Parkinson's, Alzheimer's and Huntington's diseases spread 
spatiotemporally during disease progression. The earlier the neuropathology develops in a given brain 
region, the darker the shading in the diagram. As only one view (mid-sagittal for Parkinson's and 
Alzheimer's diseases; lateral for Huntington's disease) of the brain is depicted for each disorder, not 
all relevant anatomical structures and details of the spreading patterns (indicated by arrows) are 
presented.  
 
From Brundin and colleagues (2010), reproduced with permission from Nature Publishing Group: 
Prion-like transmission of protein aggregates in neurodegenerative disease. Nature Reviews 
Molecular Cell Biology 11, 301-307 (Figure 3). 
 
Table 1 Classification, connections and functions of the dorsal thalamic nuclei  
 
Adapted from: Jones, E.G., 2007. The Thalamus, 2nd edition. Cambridge: Cambridge University Press 
(Table 3.1); Kandel, E.R., Schwartz, J.H., Jessell, T.M., 1991. Principles of Neural Science. 3rd ed., 
Prentice Hall, Sydney (Table 20-1); and Power and Looi (2014). 
 
Table 1. Classification, connections and functions of the dorsal thalamic nuclei (first order and higher order) 
 
Classification Nuclei Afferents Efferents 
Proposed functional 
domain  
First order AN subiculum and presubiculum, mammillary nuclei 
anterior limbic cortex, 
cingulate, subiculum, 
retrosplenial and presubiculum 
limbic 
 LGN retinal ganglion cells visual cortex  vision 
 MGN inferior colliculus auditory cortex of temporal lobe  hearing 
 VA substantia nigra diffuse prefrontal and cingulate motor 
 VL 
globus pallidus, deep 
cerebellar nuclei, vestibular 
nuclei, anterolateral tract 
motor and premotor cortices motor 
 VM substantia nigra, taste, vagal, spinal 
diffuse, frontal, cingulate, 
primary somatosensory and 
gustatory, medial frontal 
cortices 
integration of viscero-
motor information 
 VP medial and trigeminal lemnisci, spinothalamic tract 
primary and secondary 
somatosensory cortex 
somatic sensation of 
body and face 
Higher order LP parietal lobe, superior colliculus and pretectum parietal lobe (area 5) 
integration of sensory 
information 
 LD cingulate gyrus, fornix, pretectum, hypothalamus 
cingulate gyrus, retrosplenial 
cortex emotional expression 
 MD 
amygdaloid nuclear complex, 
olfactory cortex, 
hypothalamus, spinal, 
superior colliculus 
prefrontal cortex, including 
frontal eye field, orbitofrontal 
and lateral frontal, and basal 
olfactory structures 
limbic 
 pulvinar 
superior colliculus and 
pretectum, temporal, 
parietal and occipital lobes 
temporal, parietal, occipital 
lobes (area 5, superior 
temporal gyrus) and prestriate 
cortex 
integration of sensory 
information 
 
Adapted from: Power et al., 2015 (Table 1).  
Figure 1. Figure showing sections through the thalamus
A B C
(A) and (B) are MRI T1 weighted images of the same section of human thalamus (traced in red), with intensity settings inverted 
(using ANALYZE 11.0 software); images provided by the authors. 
(C) is a Nissl stained coronal section through Macaca Mulatta thalamus; abbreviations of relevant thalamic structures labelled: 
3V=third ventricle; CL=central lateral nucleus; CM=centre median nucleus; LD=lateral dorsal nucleus; LP=lateral posterior 
nucleus; MD=medial dorsal nucleus; Pa=paratenial nuclues; Pf=parafasciular nucleus; R=reticular thalamic nucleus; VM=ventral 
medial nucleus; VPL=ventral posterolateral nucleus; VPM=ventral posteromedial nucleus. The image in  (C) is adapted and 
sourced from BrainMaps.org, available via open access from http://brainmaps.org/ajax-viewer.jpg; (where additional 
abbreviations can be found), with license: http://creativecommons.org/licenses/by/3.0.
From Wikimedia Commons, reproduced via open access (Creative Commons); image available at 
http://commons.wikimedia.org/wiki/User:Rocket000/SVGs/Biology/Human_anatomy. License: 
http://creativecommons.org/licenses/by-sa/3.0/legalcode.
Figure 2. Schematic diagram of the thalamus (right) showing subdivisions and nuclei
Figure 3. Schematic diagram showing first order and higher order relays
A first order thalamic relay represents the first relay of peripheral or subcortical information of a particular type to a first order 
or primary cortical area. A higher order relay relays information from layer 5 of one cortical area to another cortical area; this 
can be between first order and higher order cortical area or between two higher order cortical areas. The difference is the driver 
input, which is subcortical for a first order relay and from layer 5 of cortex for a higher order relay. Abbreviations: FO=first order; 
HO=higher order; LGN=lateral geniculate nucleus; MGNd and MGNv=dorsal and ventral portions of the medial geniculate 
nucleus; PO=posterior nucleus; Pul=pulvinar; TRN=thalamic reticular nucleus; VP=ventral posterior nucleus. 
From Sherman (2006), reprinted through open access from Scholarpedia: Thalamus, 1(9):1583 
(http://www.scholarpedia.org/article/Thalamus). Link to the license: http://creativecommons.org/licenses/by-nc-
sa/3.0/legalcode.
Figure 4. Maps in the thalamus
Schematic representation of the trigemino-
thalamo-cortical pathways. The arrowheads 
indicate the termination areas of the axons. 
Note that (in the cerebral cortex) the 
postsynaptic cells may have their somata in 
other layers. The line thickness indicates the 
relative importance of the pathways. The 
barreloids in VPM are indicated in an oblique 
coronal slice, the barrelettes of the trigeminal 
nuclei in coronal slices. D = dorsal; L=lateral; 
LD=laterodorsal nucleus of the thalamus; 
Pom=medial posterior nucleus of the thalamus; 
PrV=primary trigeminal nucleus; R=rostral; 
SpVic=caudal part of spinal trigeminal nucleus 
pars interpolaris; SpVio=oral part of SpVi; 
SpVo=spinal trigeminal nucleus pars oralis; 
VPMdm=dorsomedial part of the 
ventroposterior medial nucleus of the 
thalamus; VPMh=“head” area of VPM; 
VPMvl=ventrolateral part of VPM; 
wM1=whisker motor cortex; wS1=whisker part 
of primary sensorimotor cortex; wS2=whisker 
part of secondary sensorimotor cortex.
From Bosman and colleagues (2011), 
reproduced from Frontiers via open access; 
figure available from 
http://journal.frontiersin.org/Journal/10.3389/
fnint.2011.00053/full.
Schematic diagrams illustrating the organisation of the fronto-subcortical loops within human 
brain. (a) Motor loops;  (b) Associative loops; and  (c) Limbic loops. Abbreviations: GPi=globus 
pallidus internal; GPe=globus pallidus external; STN=subthalamic nucleus.
From Volkman and colleagues (2010), reprinted with permission from Nature Publishing 
Group: Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease. Nature 
Reviews Neurology 6, 487-498.
Figure 5. Fronto-subcortical loops involving the thalamus
Figure 6. Cerebellothalamocortical circuits
A) Lateral view of the rhesus monkey brain with
hemispheres separated to expose mesial wall on top.
Arrows schematically represent cerebello-cortical
pathways relayed via cerebellar territories in lateral (left,
violet) and central thalamus (right, green). (B) Two
representative sections of the thalamus of Macaca
mulatta, viewed from a lateral anterior perspective.
Cerebellar domains in lateral and central thalamus are
presented in violet and green, respectively. (C) Same
sections as (B), but illustrating effector-related functional,
as opposed to hodological, compartments. Hatching
shows the rough somatotopic locations of regions related
to arm (vertical) and eye (diagonal) movements.
Abbreviations: DN=dentate nucleus; MIP=medial
intraparietal area; LIP=lateral intraparietal area;
M1=primary motor cortex; PMd=dorsal premotor cortex;
PMv=ventral premotor cortex; FEF=frontal eye fields;
PFc=prefrontal cortex; SMA=supplementary motor area;
pre-SMA=pre-supplementary motor area;
VLo=ventrolateral nucleus pars oralis; VPLo=
ventroposterolateral nucleus pars oralis; MD=mediodorsal
nucleus; VLc=ventrolateral nucleus pars caudalis; X=
nucleus X of the thalamus.
From Prevosto and Summer (2013), reprinted via open 
access from Frontiers: Cognitive control of movement via 
the cerebellar-recipient thalamus. Frontiers in Systems 
Neuroscience 7, 56.
Figure 7. Conceptualization of neurodegenerative 
disorders on a neural circuit basis
a). Intracellular protein aggregates can be released from neurons by
exocytosis or cell death. The aggregates are taken up by, for
example, adjacent neuronal cell bodies and are either retained in
the cell soma (local spread of pathology) or transported
anterogradely by axons. Alternatively, they are taken up by axon
terminals and transported retrogradely to the cell soma. The
protein aggregates can spread between brain regions by axonal
transport. (b-d). Three drawings propose principles for how
neuropathological changes in Parkinson's, Alzheimer's and
Huntington's diseases spread spatiotemporally during disease
progression. The earlier the neuropathology develops in a given
brain region, the darker the shading in the diagram. As only one
view (mid-sagittal for Parkinson's and Alzheimer's diseases; lateral
for Huntington's disease) of the brain is depicted for each disorder,
not all relevant anatomical structures and details of the spreading
patterns (indicated by arrows) are presented.
From Brundin and colleagues (2010), reproduced with permission 
from Nature Publishing Group: Prion-like transmission of protein 
aggregates in neurodegenerative disease. Nature Reviews 
Molecular Cell Biology 11, 301-307 (Figure 3).
